(PharmaNewsWire.Com, July 28, 2020 ) The patient positioning systems market is projected to reach USD 1,233.8 Million by 2022 from an estimated USD 990.0 Million in 2017, at a CAGR of 4.5%. The growth of the market can be attributed to rising geriatric population, growing government funding, and increasing demand for advanced medical devices.
Agreements and product launches are the main strategies followed by key players in the patient positioning systems market. Some of the leading players that adopted this strategy include Getinge AB (Sweden), Hill – Rom Holdings, Inc (U.S), C-RAD (Sweden), Merivaara Corporation (Finland) and LEONI AG (Germany).
Getinge AB (Sweden) is a key player in the patient positioning systems market. The company focuses on agreements with healthcare providers such as hospitals, ambulatory surgical centers to increase the sales as well as to strengthen its position in the patient positioning systems market. For instance in 2015, the company entered into an agreement with Hospital General de México to install the Gentinge AB’s operating room equipment that includes surgical tables. This agreement helped the company in terms of revenue generation as well as strengthening its position in the Mexican market.
Hill - Rom Holdings, Inc (U.S.) is another leading player in the market. The company offers patient positioning systems through its subsidiaries such as Trumpf Medical (U.S.) and Allen Medical (U.S.). The company mainly focuses on product launches and agreement to strengthen its position in the market. For instance in 2017, the company introduced TruSystem 3000 surgical table into the market. In 2015, the company entered into an agreement with Intuitive Surgical, Inc. (U.S.) to develop an innovative robotic-assisted device that is used in minimally invasive surgeries.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
